TCMBANKIN007858 |
pseudoaspidin |
ZINC14681710; 478-28-4; Pseudoaspidin; 1-[3-[(3-butanoyl-2,6-dihydroxy-4-methoxy-5-methylphenyl)methyl]-2,4-dihydroxy-6-methoxy-5-methylphenyl]butan-1-one; MolPort-039-339-086; AC1NSZTN |
C25H32O8 |
460.5 g/mol |
CCCC(=O)C1=C(C(=C(C(=C1O)CC2=C(C(=C(C(=C2O)C)OC)C(=O)CCC)O)O)C)OC |
TCMBANKIN020069 |
falaconitine |
|
C34H47NO10 |
629.7 g/mol |
CCN1CC2(C(CC(C34C2C(C(C31)C5=CC(C6(CC4C5C6OC(=O)C7=CC(=C(C=C7)OC)OC)O)OC)OC)OC)O)COC |
TCMBANKIN036798 |
falcarindiol |
1,9-Heptadecadiene-4,6-diyne-3,8-diol, (3R,8S,9Z)-; AIDS-185997; falcarindiol; 55297-87-5; C08449; falcarindiol ; AIDS185997; (3R,8S,9Z)-heptadeca-1,9-dien-4,6-diyne-3,8-diol |
C17H24O2 |
260.371 |
C([H])([H])=C([H])[C@]([H])(O[H])C#CC#C[C@]([H])(O[H])\C([H])=C([H])/C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] |
TCMBANKIN039043 |
indaconitine |
|
C34H47NO10 |
629.7 g/mol |
CCN1CC2(C(CC(C34C2C(C(C31)C5(CC(C6(CC4C5C6OC(=O)C7=CC=CC=C7)O)OC)OC(=O)C)OC)OC)O)COC |
TCMBANKIN058575 |
1-indanone |
2,3-dihydro-1H-inden-1-one |
C9H8O |
132.16 g/mol |
C1CC(=O)C2=CC=CC=C21 |
TCMBANKIN060932 |
trans-falcarindiol |
|
C17H24O2 |
260.37 |
CCCCCCCC=CC(C#CC#CC(C=C)O)O |
TCMBANKIN061232 |
pseudoaconitine |
|
C36H51NO12 |
689.8 g/mol |
CCN1CC2(C(CC(C34C2C(C(C31)C5(CC(C6(CC4C5C6OC(=O)C7=CC(=C(C=C7)OC)OC)O)OC)OC(=O)C)OC)OC)O)COC |